The complete Texas patient guide to Semaglutide (Wegovy/Ozempic): how it works, real cost, who qualifies, expected timeline, and city-by-city access through LeenRx telehealth.
Semaglutide is a once-weekly GLP-1 receptor agonist, the active ingredient in Wegovy (for obesity) and Ozempic (for diabetes). It reduces appetite and food noise, helping patients lose an average of 15% of body weight over 12-18 months.
Brand Wegovy/Ozempic runs $1,000-$1,500/month. LeenRx offers compounded Semaglutide from $59 the first month, with affordable monthly plans afterwards and no insurance required.
Adults with BMI ≥ 30 or BMI ≥ 27 with comorbidities. A Texas-licensed provider reviews your assessment, medical history, and current medications before approving treatment.
Mild GI symptoms (nausea, constipation), fatigue, and reduced appetite — most settle within 4-6 weeks of dose escalation. Your provider can adjust the titration schedule if symptoms persist.
Most patients see appetite changes in the first 2-4 weeks and measurable weight loss by week 8-12. Maximum results typically arrive between months 12-18 with a maintenance phase afterward.